513 related articles for article (PubMed ID: 26729459)
1. Towards new avenues in the management of lupus glomerulonephritis.
Mok CC
Nat Rev Rheumatol; 2016 Apr; 12(4):221-34. PubMed ID: 26729459
[TBL] [Abstract][Full Text] [Related]
2. Mycophenolate mofetil for lupus nephritis: an update.
Mok CC
Expert Rev Clin Immunol; 2015; 11(12):1353-64. PubMed ID: 26364748
[TBL] [Abstract][Full Text] [Related]
3. Pro: The use of calcineurin inhibitors in the treatment of lupus nephritis.
Mok CC
Nephrol Dial Transplant; 2016 Oct; 31(10):1561-6. PubMed ID: 27591327
[TBL] [Abstract][Full Text] [Related]
4. New treatment strategies for proliferative lupus nephritis: keep children in mind!
Ranchin B; Fargue S
Lupus; 2007; 16(8):684-91. PubMed ID: 17711908
[TBL] [Abstract][Full Text] [Related]
5. Lessons Learned From the Clinical Trials of Novel Biologics and Small Molecules in Lupus Nephritis.
Furie R; Toder K; Zapantis E
Semin Nephrol; 2015 Sep; 35(5):509-20. PubMed ID: 26573553
[TBL] [Abstract][Full Text] [Related]
6. Update on the management of lupus nephritis: let the treatment fit the patient.
Bertsias G; Boumpas DT
Nat Clin Pract Rheumatol; 2008 Sep; 4(9):464-72. PubMed ID: 18756272
[TBL] [Abstract][Full Text] [Related]
7. Exploring new territory: considering the future.
Schneider M
Lupus; 2007; 16(3):221-6. PubMed ID: 17432111
[TBL] [Abstract][Full Text] [Related]
8. Rituximab and mycophenolate mofetil for relapsing proliferative lupus nephritis: a long-term prospective study.
Boletis JN; Marinaki S; Skalioti C; Lionaki SS; Iniotaki A; Sfikakis PP
Nephrol Dial Transplant; 2009 Jul; 24(7):2157-60. PubMed ID: 19179411
[TBL] [Abstract][Full Text] [Related]
9. Recent news in the treatment of lupus nephritis.
Tesar V; Hruskova Z
Minerva Med; 2012 Aug; 103(4):235-51. PubMed ID: 22805617
[TBL] [Abstract][Full Text] [Related]
10. [Lupus-nephritis--diagnosis and treatment].
Norby GE; Lerang K; Holdaas H; Gran JT; Strøm EH; Draganov B; Os I; Hartmann A; Gilboe IM
Tidsskr Nor Laegeforen; 2010 Jun; 130(11):1140-4. PubMed ID: 20531500
[TBL] [Abstract][Full Text] [Related]
11. Sequential therapies for proliferative lupus nephritis.
Contreras G; Pardo V; Leclercq B; Lenz O; Tozman E; O'Nan P; Roth D
N Engl J Med; 2004 Mar; 350(10):971-80. PubMed ID: 14999109
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of systemic lupus erythematosus: myths, certainties and doubts].
Ruiz-Irastorza G; Danza A; Khamashta M
Med Clin (Barc); 2013 Dec; 141(12):533-42. PubMed ID: 23622892
[TBL] [Abstract][Full Text] [Related]
13. Treatment options for proliferative lupus nephritis: an update of clinical trial evidence.
Navaneethan SD; Viswanathan G; Strippoli GF
Drugs; 2008; 68(15):2095-104. PubMed ID: 18840001
[TBL] [Abstract][Full Text] [Related]
14. An Update on the Diagnosis and Management of Lupus Nephritis.
Kostopoulou M; Adamichou C; Bertsias G
Curr Rheumatol Rep; 2020 Jun; 22(7):30. PubMed ID: 32500443
[TBL] [Abstract][Full Text] [Related]
15. Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis.
Ginzler EM; Dooley MA; Aranow C; Kim MY; Buyon J; Merrill JT; Petri M; Gilkeson GS; Wallace DJ; Weisman MH; Appel GB
N Engl J Med; 2005 Nov; 353(21):2219-28. PubMed ID: 16306519
[TBL] [Abstract][Full Text] [Related]
16. Exploring new territory: the move towards individualised treatment.
Haubitz M
Lupus; 2007; 16(3):227-31. PubMed ID: 17432112
[TBL] [Abstract][Full Text] [Related]
17. Induction and maintenance treatment of proliferative lupus nephritis: a meta-analysis of randomized controlled trials.
Henderson LK; Masson P; Craig JC; Roberts MA; Flanc RS; Strippoli GF; Webster AC
Am J Kidney Dis; 2013 Jan; 61(1):74-87. PubMed ID: 23182601
[TBL] [Abstract][Full Text] [Related]
18. Lupus nephritis: where are we now?
Lightstone L
Curr Opin Rheumatol; 2010 May; 22(3):252-6. PubMed ID: 20305561
[TBL] [Abstract][Full Text] [Related]
19. Moderator's view: The use of calcineurin inhibitors in the treatment of lupus nephritis.
Kronbichler A; Neumann I; Mayer G
Nephrol Dial Transplant; 2016 Oct; 31(10):1572-6. PubMed ID: 27591329
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group.
Chan TM; Li FK; Tang CS; Wong RW; Fang GX; Ji YL; Lau CS; Wong AK; Tong MK; Chan KW; Lai KN
N Engl J Med; 2000 Oct; 343(16):1156-62. PubMed ID: 11036121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
